The global healthcare landscape is currently grappling with a silent but devastating epidemic that resides at the intersection of metabolic disease and vascular failure: the diabetic foot ulcer (DFU). While modern medicine has witnessed seismic shifts in the treatment of oncology, immunology, and cardiovascular disease, the management of chronic diabetic wounds has remained remarkably stagnant. […]
The U.S. Food and Drug Administration (FDA) has granted approval to Lisraya (brepocitinib), a once-daily oral medication for the treatment of dermatomyositis in adults, marking the first time a therapy has been specifically developed and approved to target the underlying inflammatory drivers of this rare autoimmune condition. Developed by Priovant Therapeutics, a subsidiary of Roivant […]
Healthcare providers across the United States have issued urgent warnings this week regarding a sophisticated and widespread phishing campaign designed to impersonate Epic’s MyChart patient portal. This coordinated cyberattack marks a significant escalation in brand impersonation tactics, leveraging the familiarity of the nation’s most widely used electronic health record (EHR) interface to deceive patients into […]
The U.S. Food and Drug Administration (FDA) has granted approval to Takeda Pharmaceutical’s Mimrylo, a first-in-class hepcidin mimetic, for the treatment of erythrocytosis in adults with polycythemia vera (PV). The regulatory milestone, announced following the close of market on Friday, introduces a novel therapeutic mechanism to a field that has long relied on invasive procedures […]
The prevailing sentiment among both patients and providers in the modern medical landscape is that technology, while advancing clinical outcomes, has simultaneously eroded the human element of care. This paradox—where more sophisticated tools lead to a more fragmented experience—has become a central challenge for healthcare administrators and technology developers alike. As clinicians spend an increasing […]
The intersection of high-stakes emergency medicine and the volatile world of venture-backed startups has emerged as a fertile ground for leadership development, revealing that the skills required to save a life on a freezing mountain are remarkably similar to those needed to save a foundering corporation. As the global economic landscape becomes increasingly unpredictable, business […]
The House Veterans’ Affairs Committee has taken the extraordinary step of voting unanimously to subpoena top leadership at Oracle Health, following a series of contentious developments regarding the Department of Veterans Affairs’ (VA) multi-billion-dollar Electronic Health Record Modernization (EHRM) program. The 19-0 vote targets Oracle CEO Mike Sicilia and Chairman/Chief Technology Officer Larry Ellison, demanding […]
The United States Food and Drug Administration (FDA) has granted approval to Zanvastro (zilganersen), marking a historic milestone as the first-ever therapy for Alexander disease, a rare and devastating neurodegenerative disorder. Developed by Carlsbad-based Ionis Pharmaceuticals, the approval encompasses both pediatric and adult patients, offering a new standard of care for a condition that previously […]
Across Tribal Nations, a multifaceted behavioral health crisis is being met with a transformative approach to recovery that prioritizes cultural identity alongside clinical excellence. Indigenous communities are currently navigating the profound impacts of a crisis rooted in generations of historical trauma, forced displacement, and chronic underinvestment in healthcare infrastructure. As substance use disorder (SUD) and […]
The Strategic Drivers of Summer 2024 M&A Activity The surge in summer deal-making was not incidental but rather a response to several converging economic pressures. According to industry analysts, hospitals have faced sustained labor shortages and inflationary pressures on medical supplies, which have compressed operating margins. By consolidating, systems aim to increase their leverage in […]
